If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 560.00
Bid: 558.00
Ask: 568.00
Change: 0.00 (0.00%)
Spread: 10.00 (1.792%)
Open: 560.00
High: 560.00
Low: 560.00
Prev. Close: 560.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

8 Jun 2011 07:00

RNS Number : 0402I
Gooch & Housego PLC
08 June 2011
 



For immediate release

8 June 2011

Gooch & Housego PLC

INTERIM REPORT FOR THE SIX MONTHS ENDED 31 MARCH 2011

Gooch & Housego PLC ('G&H' or 'the Company'), the specialist manufacturer of optical components and systems, today announces its interim results for the six months ended 31 March 2011.

Financial highlights

H1 2011

H1 2010

Increase/ (decrease)

FY 2010

Revenue

£27.2m

£20.4m

33%

£44.7m

Reported operating profit

£4.3m

£2.1m

101%

£5.9m

Reported profit before tax

£3.9m

£1.7m

130%

£5.1m

Basic earnings per share

13.0p

6.1p

113%

24.4p

Adjusted operating profit1

£5.3m

£2.6m

102%

£6.9m

Adjusted profit before tax1

£5.0m

£2.2m

128%

£6.0m

Adjusted earnings per share1

17.1p

7.9p

116%

23.1p

Net borrowing at 31 March

£5.5m

£9.3m

(41%)

£5.2m

Net Cash generated from operating activities

£5.5m

£4.0m

36%

£8.8m

1 Adjusted for amortisation of acquired intangible assets, recognition of deferred tax asset and the cost of acquisitions.

 

Operational highlights

·; Strong demand lifts revenues and profits

·; Industrial sector driven by growing use of lasers in manufacturing

·; Further diversification into Aerospace & Defence and Life Sciences, enhanced by acquisitions

·; Acquisition of EM4, Inc. a specialist manufacturer of active fibre optics

·; Acquisition of Crystal Technology, LLC, a manufacturer of acousto-optics and crystals

·; Record order book going into the second half of FY2011.

·; Interim dividend of 2.0p per share declared.

 

Gareth Jones, Chief Executive of Gooch & Housego PLC, commented on the results:

"The work we put in during 2010 has enabled us to meet the continuing strong demand for our products in 2011 and deliver an encouraging set of results for the first half of the year. The acquisitions open up many exciting opportunities for the future while accelerating the diversification of the business and consolidating Gooch & Housego's leading position in high-end photonics solutions."

 

For further information please contact:

Gooch & Housego PLC

Gareth Jones / Andy Boteler

01460 256 440

Buchanan Communications

Tim Thompson / Nicola Cronk

020 7466 5000

Investec Investment Banking (Nomad)

Patrick Robb

020 7597 5970

 

Operating & Financial Review

Performance Overview

The first six months of the 2011 financial year were characterised by favourable market conditions and strong demand for Gooch & Housego's products from the Industrial, Aerospace & Defence and Life Sciences market sectors. The period was also notable for the completion of two strategically important acquisitions.

 

 

REVENUE

Six months ended 31 March

2011

2010

2009

£,000

% of total

£,000

% of total

£,000

% of total

Industrial

15,555

57%

10,918

53%

10,770

57%

Aerospace & Defence

7,017

26%

5,257

26%

4,746

25%

Life Sciences

2,648

10%

1,752

9%

1,030

6%

Scientific Research

1,972

7%

2,446

12%

2,290

12%

Group Revenue

27,192

100%

20,373

100%

18,836

100%

 

The acquisition of EM4, Inc., a Boston, Massachusetts based specialist manufacturer of active fibre optic products, was completed and announced on 25 January 2011 after the receipt of US regulatory approval. The acquisition of Crystal Technology, a manufacturer of acousto-optic and electro-optic devices and a grower of optical crystals, was completed on 31 March 2011. These acquisitions were funded by a combination of cash (the Company raised £10.6 million, gross, via a share placing in early January 2011) and bank debt provided under a new, four-year banking facility.

 

GROUP EARNINGS PERFORMANCE

All amounts in £'000

Adjusted

Reported

Six months ended 31 March

2011

2010

 

2011

2010

Operating profit

5,322

2,633

 

4,297

2,142

Net finance costs

(297)

(429)

 

(361)

(429)

Profit before taxation

5,025

2,204

 

3,936

1,713

Earnings per share (p)

17.1

7.9

 

13.0

6.1

 

The trends established in 2010, of recovery followed by real growth in the Industrial sector (which generated an 89% increase in operating profits compared to the same period last year), combined with increasing traction in the Aerospace & Defence and Life Sciences markets (where operating profits increased by 127%), continued into 2011. The challenge of increasing production capacity to meet the demand also carried over into 2011, but thanks to the groundwork done the previous year in recruitment, training and investment in new manufacturing equipment we were able to raise output and reduce lead times. As a result Company revenues were up 33% to £27.2 million, when compared with the equivalent period last year. This included £1.0 million for two months trading in respect of our EM4 acquisition. Excluding the impact of acquisitions and on a constant currency basis, revenue grew by 29% compared to the same period last year. Adjusted profit before tax was up 128% to £5.0 million. Despite the reduction in lead times, the order book at the period end was up by 11% on a like-for-like basis, and by 41% including acquisitions, compared to 30 September 2010. At the end of March 2011 the order book stood at the record level of £32.7 million.

Both acquisitions are settling in and are performing well as the integration process progresses. The acquisitions have been well received by customers and their order intake levels since completion have been encouraging.

 

Operational & Strategy Review

Products and Markets - Industrial

The increase in the use of lasers in manufacturing, particularly in fields of microelectronics and flat panel displays, combined with the world's continuing appetite for smart phones and tablet computers, continues to be the main driver behind the demand for Gooch & Housego's acousto-optic products. It is also a significant factor in the growth in sales of electro-optics, fibre optics and precision optics. In parallel, other industrial sectors that use lasers in manufacturing, such as the automotive industry, are also experiencing growth and are contributing to the overall demand for laser components. As a result revenue in this sector increased by 42% on a like-for-like basis when compared to the same period last year. The rate of growth has stabilised in recent months to what appears to be a sustainable level, which combined with our success in increasing output, has enhanced our responsiveness.

Other industrial markets, ranging from semiconductor manufacturing & test equipment to undersea fibre optic telecommunications, also performed well in the first half of the year, driving increased sales across all product types.

Products and Markets - Aerospace & Defence

In addition to continued organic growth in this sector (18% on a like-for-like basis compared to the first six months of 2010), the acquisition of EM4 means that Gooch & Housego is now a participant in a number of significant commercial aerospace, defence and space programmes in both the US and Europe. The combination of passive fibre optic technology from Gooch & Housego's Torquay facility and EM4's active fibre optics expertise is unique, and addresses the market's stated desire to source high-level sub-assemblies in preference to low-level components. The integration of EM4 into Gooch & Housego to create a fibre optics business unit encompassing the Torquay and Boston operations is central to delivering this capability, and is already well advanced. The acquisition, and our plans to be able to provide a complete "actives & passives" capability, has been particularly well received by customers.

Products and Markets - Life Sciences

Gooch & Housego's presence in the Life Sciences sector, which also saw continued organic, like-for-like growth of 51% compared to the first six months of 2010, has similarly been strengthened by this year's acquisitions. EM4 has enhanced Gooch & Housego's capabilities in the important optical coherence tomography (OCT) market, while Crystal Technology is active in microscopy. Our development of imaging systems continues to make encouraging progress in applications such as digital pathology and diagnostics as we shift our attention from R&D towards commercialisation.

Products and Markets - Scientific

Our activities in the Scientific market are dominated by a small number of large, long term programmes. These are progressing well, but this year, as expected, we have entered a phase of lower demand. Combined with the end of stimulus funding and the continuing resolution in the US, the effect has been a 19% reduction in revenues from the Scientific sector when compared to the same period last year.

 

Acquisitions and Diversification

Through the acquisitions of EM4 and Crystal Technology, Gooch & Housego has been able to further its objective of diversification while at the same time strengthening its core capabilities in materials and materials processing. With Aerospace & Defence now likely to account for approaching one third of revenues on an annualised basis, Gooch & Housego has broadened its customer and applications base resulting in less exposure to cyclical trends. Similarly, in terms of product and technology diversification, fibre optic products now account for approximately one quarter of total revenues on an annualised basis, up from zero four years ago.

The acquisition of Crystal Technology consolidates Gooch & Housego's market leadership position in acousto-optics and brings self-sufficiency in the strategically important crystals tellurium dioxide and lithium niobate. These materials in turn open up new opportunities in defence, telecommunications and consumer applications. As well as ensuring adequate supply, self-sufficiency in these materials supports our objective to control all critical aspects of the product that affect performance, quality and price, which is key to maintaining our leadership in the market.

Cash Flow and Financing

In the six months to 31 March 2011 Gooch & Housego generated net cash from operations of £5.5 million, compared to £4.0 million in the same period of 2010. Working capital increased by £0.1 million in the six month period to 31 March 2010 (2010: reduction of £0.7 million). Tax payments during the first six months of 2011 were £1.0 million compared to £0.5 million in 2010.

The ratio of operating cash flows to EBITDA was 95%. (2010: 109%)

Capital expenditure on property, plant and equipment increased to £1.2 million (2010: £0.2 million).

On 5 January 2011, Gooch & Housego raised approximately £10.2 million (net of expenses) through a placing of new 20p Ordinary Shares, and an additional £5 million in debt, in order to fund the acquisitions of EM4 Inc., and Crystal Technology LLC.

Acquisition Summary

EM4

Crystal Technology

£'ms

£'ms

Initial purchase price

7.3

6.6

Expected earn out - payable 31 March 2012

2.0

-

Deferred consideration - payable 31 March 2012

-

2.0

Total purchase price

9.3

8.6

 

 

Cash, cash equivalents and bank overdrafts as at 31 March 2011 amounted to a positive cash position of £9.0 million, compared to £5.7 million at 30 September 2010, an improvement of £3.3 million.

Net debt reduced from £9.3 million at 31 March 2010 to £5.5 million at 31 March 2011, a reduction of 41% in absolute terms and 35% if measured on a constant currency basis. Since 30 September 2010, net debt has increased by 6%. The movement in net debt is outlined in the table below.

 

MOVEMENT IN NET DEBT

All amounts in £'ms

Gross cash

Gross debt

Net debt

At 1 October 2010

8.3

(13.5)

(5.2)

Net cash flows from trading

5.5

-

5.5

Share placing

10.6

-

10.6

Debt funding

4.7

(4.7)

-

Debt repayments

(1.2)

1.2

-

Acquisitions

(14.4)

-

(14.4)

Capital Expenditure

(1.2)

-

(1.2)

Working capital

(0.1)

-

(0.1)

Interest & dividends

(0.7)

-

(0.7)

At 31 March 2011

11.5

(17.0)

(5.5)

 

On 1 April 2011, Gooch & Housego renegotiated its banking facilities with its current bankers, the Royal Bank of Scotland. These facilities now comprise an $18 million dollar denominated term loan (fully drawn down), a £3.1 million sterling denominated term loan (fully dawn down), an $8 million revolving credit facility (drawn to $4 million as at 31 March 2011) and an undrawn capital expenditure facility of $8 million. All facilities are committed until April 2015.

The Company has reported compliance with banking covenants since January 2009. The Group monitors its financial performance against these covenants on a regular basis. Based upon its forecasts and current trading conditions, the Group considers that it has sufficient headroom to operate within these covenants.

Based on the Company's current financial position and anticipated trading performance, the Directors are confident that the Company has adequate resources to continue as a going concern for at least the next twelve months.

People

As a result of our recruitment efforts and the recent acquisitions Gooch & Housego's headcount has increased by 25% to 576 since 1 October 2010. A particular benefit of the acquisitions has been the influx of highly skilled and capable people across all functions of the business, including at senior management level. We would like to welcome them to Gooch & Housego and thank all employees for their help in delivering a positive start to the year.

 

Dividends

The Directors have declared an interim dividend of 2.0p per share. This will be payable on 15 July 2011 to shareholders on the register as at 17 June 2011.

Summary & Outlook

Favourable trading conditions combined with success in increasing output and developing new markets has helped us to achieve encouraging results for the first six months of the year. The acquisitions of EM4 and Crystal Technology have enhanced Gooch & Housego's leading position in acousto-optics and high-end fibre optics, accelerated our diversification into new markets, decreased our exposure to cyclicality and reduced risk by securing our supply chain. Our priorities in the second half of the year are to integrate and consolidate the new acquisitions in order to deliver the considerable upside potential that they provide, while continuing to execute existing opportunities in a trading environment that remains favourable.

 

 

 

Julian Blogh Gareth Jones Andrew Boteler

Chairman Chief Executive Officer Chief Financial Officer

8 June 2011 8 June 2011 8 June 2011

Unaudited interim results for the 6 months ended 31 March 2011

 

Group Income Statement

Note

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to

30 Sep 2010(Audited)

£000

£000

£000

Revenue

5

27,192

20,373

44,683

Cost of revenue

(15,252)

(12,725)

(25,992)

Gross profit

11,940

7,648

18,691

Research & Development

(1,654)

(1,255)

(2,834)

Sales & Marketing

(1,623)

(1,083)

(2,529)

Administration and other expenses

(4,602)

(3,397)

(7,768)

Other income

236

229

369

Operating profit

5

4,297

2,142

5,929

Net finance costs

(361)

(429)

(833)

Profit before income tax expense

3,936

1,713

5,096

Income tax expense

6

(1,283)

(544)

(405)

Profit for the period

2,653

1,169

4,691

Earnings per share

 

7

13.0p

6.1p

24.4p

 

 

Reconciliation of operating profit to adjusted operating profit:

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to 30 Sep 2010(Audited)

£000

£000

£000

Operating profit

4,297

2,142

5,929

Amortisation of acquired intangible assets

530

491

934

Acquisition costs

 

495

-

-

Adjusted operating profit

5,322

2,633

6,863

 

 

Reconciliation of net finance costs to adjusted net finance costs:

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to 30 Sep 2010(Audited)

£000

£000

£000

Net finance costs

(361)

(429)

(833)

Costs associated with debt re-financing

64

-

-

Adjusted net finance costs

(297)

(429)

(833)

Unaudited interim results for the 6 months ended 31 March 2011

 

Group Balance Sheet

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to

30 Sep 2010(Audited)

£000

£000

£000

Non-current assets

Property, plant & equipment

19,713

16,163

15,753

Intangible assets

24,643

16,793

15,291

Deferred income tax assets

4,512

1,560

3,092

48,868

34,516

34,136

Current assets

Trade and other receivables

10,440

7,703

7,595

Inventories

9,557

6,412

7,281

Income tax receivable

364

449

168

Cash and cash equivalents

11,520

7,137

8,285

31,881

21,701

23,329

Current liabilities

Borrowings

(4,951)

(6,471)

(4,981)

Trade and other payables

(11,845)

(5,817)

(6,650)

Income tax liabilities

(553)

(205)

-

Provision for other liabilities and charges

(373)

(348)

(369)

(17,722)

(12,841)

(12,000)

Net current assets

14,159

8,860

11,329

Non-current liabilities

Borrowings

(12,044)

(9,975)

(8,545)

Deferred income tax liabilities

(1,214)

(568)

(696)

Derivative financial instruments

(104)

(180)

(171)

(13,362)

(10,723)

(9,412)

Net assets

49,665

32,653

36,053

Shareholders' equity

Capital and reservesattributable to equity shareholders

Called up share capital

4,370

3,853

3,853

Share premium account

14,200

4,105

4,105

Merger reserve

2,671

2,671

2,671

Hedging reserve

(125)

(182)

(184)

Cumulative translation reserve

55

1,033

276

Retained earnings

28,494

 

21,173

25,332

Equity Shareholders' Funds

49,665

32,653

36,053

 

Unaudited interim results for the 6 months ended 31 March 2011

 

Group Statement of Changes

in Equity

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to

30 Sep 2010(Audited)

£000

£000

£000

Balance at beginning of period

36,053

30,798

30,798

Dividends paid

(434)

-

-

Post dividend opening balance

35,619

30,798

30,798

Shares issued (net of costs)

10,611

-

-

Fair value adjustment of interest rate swap

60

4

2

Exchange difference on translation of foreign operations

(222)

549

(208)

Net income recognised directlyin equity

10,449

553

(206)

Profit for the period

2,653

1,169

4,691

Total comprehensive income for the period

13,102

1,722

4,485

Employee share option schemes:

- Deferred tax on share based payment charges

709

-

417

- Share based payment accounting charge

235

133

353

944

133

770

Balance at end of the period

49,665

32,653

36,053

 

 

Consolidated statement of comprehensive income

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to

30 Sep 2010(Audited)

£000

£000

£000

Profit for the period

2,653

1,169

4,691

Other comprehensive income

Exchange difference on translation of foreign operations

(222)

549

(208)

Fair value adjustment of interest rate swap

60

4

2

Other comprehensive income/(expense) for the period

(162)

553

(206)

Total comprehensive income for the period

2,491

1,722

4,485

Total comprehensive income for the period is attributed to :

Shareholders of Gooch & Housego PLC

2,491

1,722

4,485

Unaudited interim results for the 6 months ended 31 March 2011

 

Group Cash Flow Statement

Note

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to 30 Sep 2010(Audited)

£000

£000

£000

Cash flows from operating activities

Cash generated from operations

10

6,512

4,508

10,142

Income tax paid

(976)

(495)

(1,307)

Net cash generated from operating activities

5,536

4,013

8,835

Cash flows from investing activities

Acquisition of subsidiaries

(14,408)

-

-

Purchase of property, plant and equipment

(1,207)

(280)

(873)

Sale of property, plant and equipment

4

-

7

Purchase of intangible assets

(65)

(27)

(81)

Interest received

5

-

2

Net cash used in investing activities

(15,671)

(307)

(945)

Cash flows from financing activities

Proceeds from borrowings

4,676

-

38

Repayment of borrowings

(1,218)

(1,200)

(2,447)

Issuance of share capital

10,611

-

-

Dividends paid to ordinary shareholders

(434)

-

-

Interest paid

(247)

(334)

(750)

Net cash generated/(used in) from financing activities

13,388

(1,534)

(3,159)

Net increase in cash, cash equivalents and bank overdraft

3,253

2,172

4,731

Cash, cash equivalents and bank overdraft at beginning of the period

5,746

1,087

1,087

Exchange gains/(losses) on cash and bank overdrafts

26

(78)

(72)

Cash, cash equivalents and bank overdrafts at the end of the period

9,025

3,181

5,746

 

 Cash, cash equivalents and bank overdrafts at the end of the period are made up of:

 

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to

30 Sep 2010(Audited)

£000

£000

£000

Cash and cash equivalents

11,520

7,137

8,285

Bank overdraft

(2,495)

(3,956)

(2,539)

Cash, cash equivalents and bank overdrafts at the end of the period

9,025

3,181

5,746

Notes to the Interim Report

 

1. Basis of Preparation

 

The unaudited Interim Report has been prepared under the historical cost convention and in accordance with International Financial Reporting Standards ("IFRS"), as adopted by the European Union.

 

The Interim Report was approved by the Board of Directors and the Audit Committee on 7 June 2011. The Interim Report does not constitute statutory financial statements within the meaning of the Companies Act 2006 and has not been audited.

 

Comparative figures in the Interim Report for the year ended 30 September 2010 have been taken from the Group's audited statutory financial statements on which the Group's auditors, PricewaterhouseCoopers LLP, expressed an unqualified opinion. The comparative figures to 31 March 2010 are unaudited.

 

The Interim Report will be announced to all shareholders on the London Stock Exchange and published on the Group's website on 8 June 2011. Copies will be available to members of the public upon application to the Company Secretary at Dowlish Ford, Ilminster, Somerset, TA19 0PF.

 

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 September 2010, as described in those financial statements, save for the adoption of the new standards referred to below.

2. Recent Accounting Developments

 

The following standards and amendments became effective for the current reporting period:

IFRS 2 (amendment) Group Cash-Settled Share-Based Payments

IFRIC 19 Extinguishing Financial Liabilities with Equity Instruments

 

Application of these standards and interpretations has not had a material impact on the net assets of the Group.

The following standards and interpretations were issued but application was not mandatory for the period:

 

IFRS 9 Prepayment of Minimum Funding Requirement

 

The Directors anticipate that the adoption of these standards and interpretations will have no material impact on the net assets or results of the Group.

 

3. Estimates

 

The preparation of interim financial statements requires management to make estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.

 

In preparing these condensed consolidated interim financial statements, the significant judgements made by management in applying the Company's accounting policies and the key sources of estimation uncertainty were the same as those that applied to the consolidated financial statements for the year ended 30 September 2010, with the exception of changes in estimates that are required in determining the provision for income taxes.

 

4. Financial risk management

 

4.1 Financial risk factors

 

The Company's activities expose it to a variety of financial risks, market risk (including currency risk, cash flow interest rate risk and price risk), credit risk and liquidity risk.

 

The interim condensed consolidated financial statements do not include all financial risk management information and disclosures required in the annual financial statements and should be read in conjunction with the Company's annual financial statements as at 30 September 2010.

 

There have been no changes in the risk management policies since the year end.

 

4.2 Liquidity risk

 

Since 30 September 2010, Gooch & Housego has raised £10.2 million (net of expenses) through a share placing and increased its debt facility by £5.0 million in order to fund two acquisitions. Under deferred and conditional consideration arrangements associated with the acquisition of Crystal Technology LLC and EM4 Inc, the Company is obliged to pay the former owners of these companies an estimated $6.6 million on the 31 March 2012.

 

Except as above there have been no material changes in contractual undiscounted cash flows for financial liabilities.

 

 

5. Segmental analysis

Aerospace & Defence

Life Sciences

Industrial

Scientific Research

Corporate

Total

£000

£000

£000

£000

£000

£000

For half year to 31 March 2011

Revenue

Total revenue

7,017

2,648

16,776

1,972

-

28,413

Inter and intra-division

-

-

(1,221)

-

-

(1,221)

External revenue

7,017

2,648

15,555

1,972

-

27,192

Divisional expenses

(5,318)

(1,985)

(10,934)

(1,738)

(1,370)

(21,345)

EBITDA¹

1,699

663

4,621

234

(1,370)

5,847

EBITDA %

24.2%

25.0%

29.7%

11.9%

-

21.5%

Depreciation & Amortisation

(225)

(55)

(285)

(44)

(411)

(1,020)

Operating profit before amortisation of acquired intangible assets

1,474

608

4,336

190

(1,781)

4,827

Acquired intangible assets amortisation

-

-

-

-

(530)

(530)

Operating profit

1,474

608

4,336

190

(2,311)

4,297

Operating profit margin %

21.0%

23.0%

27.9%

9.6%

-

15.8%

  

 

5. Segmental analysis (continued)

Aerospace & Defence

Life Sciences

Industrial

Scientific Research

Corporate

Total

£000

£000

£000

£000

£000

£000

For half year to 31 March 2010

Revenue

Total revenue

5,257

1,752

12,273

2,489

-

21,771

Inter and intra-division

-

-

(1,355)

(43)

-

(1,398)

External revenue

5,257

1,752

10,918

2,446

-

20,373

Divisional expenses

(4,289)

(1,519)

(8,329)

(2,100)

(438)

(16,675)

EBITDA¹

968

232

2,589

346

(438)

3,698

EBITDA %

18.4%

13.3%

23.7%

14.1%

-

18.2%

Depreciation & Amortisation

(215)

(69)

(298)

(76)

(407)

(1,065)

Operating profit before amortisation of acquired intangible assets

753

164

2,291

270

(845)

2,633

Acquired intangible assets amortisation

-

-

-

-

(491)

(491)

Operating profit

753

164

2,291

270

(1,336)

2,142

Operating profit margin %

14.3%

9.4%

21.0%

11.0%

-

10.5%

 

¹EBITDA = Earnings before interest, tax, depreciation and amortisation.

 

All of the amounts recorded are in respect of continuing operations.

 

 

Analysis of revenue by destination

 

Half year to

31 March 2011

(Unaudited)

Half year to

31 March 2010

(Unaudited)

£000

£000

United Kingdom

4,212

2,816

America

11,490

10,063

Continental Europe

5,350

3,354

Asia/Pacific

6,034

4,095

Other

106

45

27,192

20,373

 

Sales between segments are made on normal commercial terms.

 

6. Income tax expense

 

Analysis of tax charge in the year to date

Half Year to

31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to 30 Sep 2010 (Audited)

£000

£000

£000

Current taxation

UK Corporation tax

617

-

47

Overseas tax

793

685

1,513

Adjustments in respect of prior year tax charge

60

-

(46)

Total current tax

1,470

685

1,514

Deferred tax

Origination and reversal of timing differences

(301)

(86)

(622)

Adjustments in respect of prior year deferred tax

84

(55)

(506)

Impact of tax rate change to 26% (2010: 27%)

30

-

19

Total deferred tax

(187)

(141)

(1,109)

Income tax expense per income statement

1,283

544

405

 

 

Adjusted income tax workings

Half Year to

31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to 30 Sep 2010 (Audited)

£000

£000

£000

 

Income tax expense per income statement

1,283

544

405

Add back one-off items:

Losses utilised not previously recognised

-

10

350

Unutilised tax losses to be consumed in future years

-

-

564

Increase in deferred tax on 2004 and 2005 options

-

-

210

Total on-off items

-

10

1,124

Adjusted income tax expense

1,283

554

1,529

 

Income tax expense for the six months ended 31 March 2011 and 31 March 2010, respectively, has been estimated at prevailing rates. Taxation for the year ended 30 September 2010 is the actual provision for the year.

  

 

7. Earnings per share

 

The calculation of earnings per 20p Ordinary Share is based on the profit for the period using as a divisor the weighted average number of Ordinary Shares in issue during the period. The weighted average number of shares is given below.

 

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to 30 Sep 2010(Audited)

No.

No.

No.

Number of shares used for basic earnings per share

20,477,083

19,264,390

19,264,390

Dilutive shares

409,444

88,408

432,834

Number of shares used for dilutive earnings per share

20,886,527

19,352,798

19,697,224

 

A reconciliation of the earnings used in the earnings per share calculation is set out below:

 

Half Year to31 Mar 2011 (Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to30 Sep 2010(Audited)

£000

p pershare

£000

p pershare

£000

p pershare

Basic earnings per share

2,653

13.0p

1,169

6.1p

4,691

24.4p

Adjustments net of income tax expense:

Amortisation of acquired intangible assets

407

2.0p

354

1.8p

860

4.5p

Acquisition costs

380

1.9p

-

-

-

-

Costs associated with debt re-financing

49

0.2p

-

-

-

-

Impact of one-off tax adjustments

-

-

-

-

(1,124)

(5.8p)

Total adjustments net of income tax expense

836

4.1p

354

1.8p

(264)

(1.3p)

Adjusted basic earnings per share

3,489

17.1p

1,523

7.9p

4,427

23.1p

 

Adjusted earnings per share before amortisation and adjustments has been shown because, in the opinion of the Directors, it more accurately reflects the trading performance of the Group.

 

 

8. Dividend

 

The Directors have declared an interim dividend of 2.0 pence per share for the half year ending 31 March 2011. This dividend has not been accounted for within the period to 31 March 2011 as it is yet to be paid.

 

No dividends were paid in the comparative periods.

 

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to 30 Sep 2010(Audited)

£000

£000

£000

Final 2010 dividend paid.

434

-

-

434

-

-

 

9. Borrowings

 

On 1 April 2011, Gooch and Housego renegotiated its banking facilities with its current bankers, the Royal Bank of Scotland. These facilities now comprise of an $18m dollar denominated term loan (fully drawn down) and a £3.1m sterling denominated term loan (fully dawn down).

The Company has a working capital facility of US$8.0m of which US$4.0m is drawn down.

 

In addition the Group has been granted a capital expenditure facility of US$8.0m, which has not been drawn down.

 

All facilities are committed until April 2015 and attract an interest rate of between 2.25% and 3.00% above LIBOR dependent upon the Company's leverage ratio.

 

 

10. Cash generated from operating activities

Half Year to31 Mar 2011(Unaudited)

Half Year to31 Mar 2010(Unaudited)

Full Year to

30 Sep 2010(Audited)

£000

£000

£000

Profit before income tax

3,936

1,713

5,096

Adjustments for:

- Amortisation of acquired intangible assets

530

491

934

- Amortisation of other intangible assets

167

167

356

- Depreciation

854

895

1,796

- (Loss)/Profit on disposal of property, plant

and equipment

 

15

-

(2)

- Share based payments

235

133

412

- Acquisition costs

495

-

-

- Finance income

(5)

(1)

(2)

- Finance costs

366

430

835

Total

2,657

2,115

4,329

Changes in working capital

- Inventories

(622)

809

(484)

- Trade and other receivables

(597)

(1,015)

(1,333)

- Trade and other payables

732

804

864

- Provisions for liabilities and charges

406

82

1,670

Total

(81)

680

717

Cash generated from operating activities

6,512

4,508

10,142

 

 

11. Acquisition of EM4 Inc

 

On 25 January 2011, the company acquired the entire share capital of EM4 Inc. a US based manufacturer of active fibre optics components and subassemblies, based near Boston, Massachusetts for an initial consideration of $11.6 million (approximately £7.3 million). To fund this acquisition, the Company raised approximately £10.6 million (approximately £10.2 million net of expenses) through a placing of new ordinary shares at 450 pence per new ordinary share, on 5 January 2011.

 

 

The following table summarises the consideration paid for EM4 Inc., and the provisional fair values of the assets and liabilities at the acquisition date.

 

Provisional fair value

£000

Property, plant and equipment

138

Intangible assets

1,546

Cash

489

Trade and other receivables

891

Inventory

560

Trade and other payables

(1,010)

Deferred tax

864

Net assets acquired

3,478

Consideration paid:

Cash

7,274

Contingent consideration

2,001

Total consideration

9,275

Goodwill

5,797

 

The goodwill in respect of this acquisition arises from a number of sources including well established customer relationships with many of the major US defence contractors, world leading technology, and a well-respected brand.

 

The contingent consideration arrangement requires Gooch & Housego to pay the sum of 1.2 times the EBITDA generated by EM4 Inc. in calendar year 2011.

 

The potential undiscounted amount of all future payments that Gooch & Housego could be required to make under this arrangement is between nil and $7.0 million.

 

The fair value of the contingent consideration arrangement of £2.0 million was estimated by reference to latest business forecasts.

 

The fair values of the net assets acquired are provisional pending finalisation of the fair value exercise in relation to those assets.

 

The revenue included in the consolidated income statement from 23 January 2011 to 31 March 2011 contributed by EM4 Inc. was £1.0 million. EM4 Inc. also contributed profit of £0.1 million over the same period.

 

 

12. Acquisition of Crystal Technologies LLC.

 

On 31 March 2011, the company acquired the entire share capital of Crystal Technology LLC, a Palo Alto, California, based manufacturer of acousto-optic, electro-optic and fibre optic components and systems, and oxide single crystal materials for optical applications. The total consideration of $13.75 million (approximately £8.6 million) comprises $9.625 million for the business and $4.125 million in respect of near cash equivalents being left in the business at acquisition.

 

 

The following table summarises the consideration paid for Crystal Technology LLC, and the provisional fair values of the assets and liabilities at the acquisition date.

 

 

Provisional fair value

£000

Property, plant and equipment

3,764

Intangible assets

1,832

Trade and other receivables

1,659

Inventory

1,632

Trade and other payables

(576)

Deferred tax

249

Net assets acquired

8,560

Consideration paid:

Cash

6,586

Deferred consideration

1,977

Total consideration

8,563

Goodwill

3

The goodwill in respect of this acquisition arises from a number of sources including technology in key crystal growth capabilities and a well-respected brand.

 

The deferred consideration arrangement requires Gooch & Housego to pay the sum of $3.25 million on 31 March 2011.

 

The fair values of the net assets acquired are provisional pending finalisation of the fair value exercise in relation to those assets.

 

As Crystal Technology was acquired on 31 March 2011 it contributed no revenue or profits to the current period.

  

13. Called Up Share Capital

 

2011

No.

2010

No.

2011

£000

2010

£000

Authorised

Ordinary share of 20p each

 

24,000,000

 

24,000,000

 

4,800

 

4,800

Allotted, issued and fully paid

Ordinary share of 20p each

 

21,850,798

 

19,264,390

 

4,370

 

3,853

 

 

 

14. Derivative financial instruments

Half Year to31 Mar 2011 (Unaudited)

Half Year to31 Mar 2010 (Unaudited)

Full Year to30 Sep 2010(Audited)

£000

£000

£000

Interest rate swap

173

252

256

Current portion

69

72

85

Non-current portion

104

180

171

173

252

256

 

The notional principal amount of the outstanding interest swap contract at 31 March 2011 was $7.7 million (2010: $10.3 million). The end date for the interest rate swap is 14 October 2013.

 

At 31 March 2011, the fixed rate of the interest rate swap was 3.19% and the floating rate was US dollar LIBOR.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFEARDIDIIL
Date   Source Headline
4th Apr 20247:00 amRNSHalf Year Trading Update
18th Mar 20242:36 pmRNSDivestment of EM4
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20243:26 pmRNSNotification of Major Holdings
22nd Feb 20244:07 pmRNSNotification of Major Holdings
21st Feb 202412:31 pmRNSResult of AGM
21st Feb 202410:28 amRNSDirector/PDMR Shareholding
21st Feb 20249:43 amRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSAGM Trading Update
12th Jan 20247:00 amRNSAnnual Report and Notice of AGM
10th Jan 20247:00 amRNSGrant of LTIP Awards
9th Jan 202411:53 amRNSNotification of Major Holdings
8th Jan 20243:57 pmRNSNotification of Major Holdings
4th Jan 20243:20 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSResults for the year ended 30 September 2023
8th Nov 20237:00 amRNSNotification of Full Year Results
23rd Oct 20232:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSFull Year Trading Update
2nd Oct 20232:44 pmRNSHolding(s) in Company
9th Aug 20236:15 pmRNSDirector/PDMR Shareholding
31st Jul 20238:22 amRNSHolding(s) in Company
21st Jul 202311:58 amRNSCompletion of Acquisition and Issue of Equity
19th Jul 20237:00 amRNSAcquisition of Artemis Optical
23rd Jun 20234:11 pmRNSHolding(s) in Company
21st Jun 202310:26 amRNSDirector/PDMR Shareholding
20th Jun 20236:00 pmRNSAcquisition of GS Optics
6th Jun 20237:00 amRNSInterim Results
23rd May 20237:00 amRNSNotification of Half Year Results
3rd May 20238:56 amRNSIssue of Equity
4th Apr 20237:00 amRNSHalf Year Trading Update
30th Mar 20239:33 amRNSHolding(s) in Company
15th Mar 202312:00 pmRNSAppointment of Non-Executive Director
3rd Mar 20234:37 pmRNSHolding(s) in Company
2nd Mar 20231:10 pmRNSHolding(s) in Company
1st Mar 20239:44 amRNSHolding(s) in Company
22nd Feb 20231:50 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Trading Update
8th Feb 202312:59 pmRNSHolding(s) in Company
9th Jan 202311:44 amRNSGrant of LTIP Awards
21st Dec 202210:02 amRNSPosting of Annual Report and Notice of AGM
20th Dec 202212:30 pmRNSDirector/PDMR Shareholding
6th Dec 20224:26 pmRNSDirector/PDMR Shareholding
6th Dec 20229:38 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSResults for the year ended 30 September 2022
25th Nov 20223:17 pmRNSHolding(s) in Company
23rd Nov 20224:27 pmRNSHolding(s) in Company
18th Nov 20222:20 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSNotification of Full Year Results
27th Oct 202212:56 pmRNSHolding(s) in Company
18th Oct 20222:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.